Article Text
DTB select
Tranexamic acid should be avoided for acute gastrointestinal bleeds
Abstract
Overview of: The HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020; 395:1927–36.
- drug-related side effects and adverse reactions
- healthcare quality
- access
- evaluation